Evidence map›Paper›PMID 22169210›Full record

ArticleNeuron glia biology2010

Developmental regulation of group I metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia.

Lauren L Jantzie, Delia M Talos, Debra B Selip, Li An, Michele C Jackson, Rebecca D Folkerth, Wenbin Deng, Frances E Jensen

Abstract read
In one paragraph

Article in Neuron glia biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Lauren L JantzieDepartment of Neurology, Children's Hospital Boston and Harvard Medical School, Boston, MA 02115, USA.
Delia M Talos
Debra B Selip
Li An
Michele C Jackson
Rebecca D Folkerth
Wenbin Deng
Frances E Jensen
Harvard University Press · USBoston Children's Hospital · USHarvard University · USCalifornia Institute for Regenerative Medicine · US

Funding

PERIVENTRICULAR LEUKOMALACIA IN THE PREMATURE INFANTP01NS038475 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI VOLPE, JOSEPH J · 2000 to 2009
$13.2M
Understanding the Cognitive Impact of Early Life EpilepsyDP1OD003347 · OD · UNIVERSITY OF PENNSYLVANIA · PI JENSEN, FRANCES E · 2007 to 2011
$4.2M
The Epileptogenic Effect of Perinatal HypoxiaR01NS031718 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI JENSEN, FRANCES E · 1997 to 2011
$3.8M
NIH HHS DP1 OD003347NIH HHS DP1-OD003347NINDS NIH HHS P01 NS038475NINDS NIH HHS P01-NS038475NINDS NIH HHS R01 NS031718NINDS NIH HHS R01-NS31718
6 · The paper itself

Abstract

Cerebral white matter injury in premature infants, known as periventricular leukomalacia (PVL), is common after hypoxia-ischemia (HI). While ionotropic glutamate receptors (iGluRs) can mediate immature white matter injury, we have previously shown that excitotoxic injury to premyelinating oligodendrocytes (preOLs) in vitro can be attenuated by group I metabotropic glutamate receptor (mGluR) agonists. Thus, we evaluated mGluR expression in developing white matter in rat and human brain, and tested the protective efficacy of a central nervous system (CNS)-penetrating mGluR agonist on injury to developing oligodendrocytes (OLs) in vivo. Group I mGluRs (mGluR1 and mGluR5) were strongly expressed on OLs in neonatal rodent cerebral white matter throughout normal development, with highest expression early in development on preOLs. Specifically at P6, mGluR1 and mGLuR5 were most highly expressed on GalC-positive OLs compared to neurons, axons, astrocytes and microglia. Systemic administration of (1S,3R) 1-aminocyclopentane-trans-1,3,-dicarboxylic acid (ACPD) significantly attenuated the loss of myelin basic protein in the white matter following HI in P6 rats. Assessment of postmortem human tissue showed both mGluR1 and mGluR5 localized on immature OLs in white matter throughout development, with mGluR5 highest in the preterm period. These data indicate group I mGluRs are highly expressed on OLs during the peak period of vulnerability to HI and modulation of mGluRs is protective in a rodent model of PVL. Group I mGluRs may represent important therapeutic targets for protection from HI-mediated white matter injury.

Indexed as

Age FactorsAnimalsAnimals, NewbornBrainDioxolanesDisease Models, AnimalFetusGalactosylceramidaseGene Expression Regulation, DevelopmentalHumansHypoxia-Ischemia, BrainInfant, NewbornLeukomalacia, PeriventricularOligodendrogliaPurinesRats4-(2-amino-6-chloro-9H-purin-9-yl)-1,3-dioxolane-2-methanolDioxolanesGalactosylceramidaseGRM5 protein, humanGrm5 protein, ratmetabotropic glutamate receptor type 1PurinesReceptor, Metabotropic Glutamate 5Receptors, Metabotropic Glutamate

Identifiers

PMID22169210
PMCPMC6732218
OpenAlexW2074687638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.